A future where ambient technology is integrated across all hospital spaces — patient rooms, ORs, even waiting areas — will revolutionize decision-making to improve care. The post Improving Care Delivery With Ambient Technology appeared first on MedCity News.
The shortfalls that accompany this technology gap touch everything from continuity of care and outcomes to the patient experience. The post Mind The Gaps: Closing the Digital Divide to Improve Behavioral Healthcare appeared first on MedCity News.
President Donald Trump has nominated Robert F. Kennedy Jr., an environmental lawyer with no formal medical or public health expertise, as secretary of Health and Human Sciences. Two Senate committees will question Kennedy this week on how his disproven views of science and medicine qualify him to run the $1.7 trillion, 80,000-employee federal health system….
A new partnership between TeamHealth and Array Behavioral Care aims to enhance mental health support in emergency departments. The post TeamHealth, Array Behavioral Care Partner to Advance Emergency Behavioral Health Treatment appeared first on MedCity News.
This chart collection compare health outcomes, quality of care, and access to services between the U.S. and peer countries. While inconsistent and imperfect metrics make it difficult to firmly assess system-wide health quality in the U.S., a review of the available data prior to the onset of the COVID-19 pandemic suggests that in most of…
Without a clear picture of which solutions are working and which ones aren’t, it’s difficult for providers to scale AI across their enterprise. As hospitals transition their AI efforts from experimentation mode to the widespread adoption phase, experts agree that more rigorous, real-world evidence is needed. The post Why Providers Are Stalling When It Comes…
AmplifyMD raised a $20 million Series B round for its AI-driven virtual specialty care platform and physician network. Memorial Hermann Health System, both a customer and investor, uses the platform to fill specialty gaps and improve workflows. The post AmplifyMD Snags $20M to Help Hospitals Scale Virtual Specialty Care appeared first on MedCity News.
Regulus Therapeutics drug farabursen is a potential first-in-class treatment for a rare kidney disease whose only FDA-approved therapy introduces severe toxicity risks. Farabursen is joining a Novartis drug lineup spanning several therapies for rare renal disorders. The post Novartis Gets Phase 3-Ready Rare Kidney Disease Drug via $800M Regulus Acquisition appeared first on MedCity News.
How does patient quality of life impact caregiving burden? Often this is determined using caregiver surveys. However, a paper by Jiao et al. (2025) aims to use a data based approach to help estimate caregiver burden. They The authors use data from the 2010-2018 Health and Retirement Survey (HRS). HRS data was selected because there…
Iambic’s latest financing follows the presentation of data for its breast cancer drug during the recent European Society of Medical Oncology conference. Our financing roundup includes capital raised by startups developing novel therapies immunology, metabolic disorders, genetic diseases, and more. The post Startup Iambic Raises $100M for Clinical Trials of AI-Discovered Cancer Drugs appeared first…